Respiree
Singapore’s Respiree closes $11.6M Series A financing round led by We Venture Capital and ClavystBio
Respiree, a Singapore-based health tech company with artificial intelligence (AI) platforms, has announced the successful closing of a $11.6 million Series A financing round led by We Venture Capital and ClavystBio.
July 24, 2025
Singapore’s Temasek restructures to focus on key investments
August 29, 2025
Singapore’s Temasek restructures to focus on key investments
August 29, 2025